Physician-scientist. Dad. Husband. Associate Professor @yaleibio @yale_labmed. We study host-viral interactions #covid #norovirus @wilenlab.bsky.social
Excited to share our new preprint identifying endothelial protein C receptor (EPCR) as a receptor for Langya virus. Langya was identified in 2022 in patients with acute febrile illness and linked to shrews biorxiv.org/content/10.64898…@YaleMed@YaleIBIO@NIH
And a third article in the same issue of science, showing a reconstruction of the Bundibugyovirus outbreak science.org/doi/epdf/10.1126… the hanta and ebola papers have in common that they highlight the importance of combined detailed outbreak investigations, lab work and analytics
This is just the best study I've read all year. Just incredible epi/genetics work. Wow. Also shows always keep your samples!
nature.com/articles/s41586-0…
Our bodies are colonized by trillions of viruses that we live with in homeostasis. The most diverse and abundant of these viral families are anelloviruses. A new paper from us at @MSKCancerCenter explores what happens after we *all* have been infected
biorxiv.org/content/10.64898… 1/n
Today, we released the National Policy for Nucleic Acid Synthesis Screening to protect American biotechnology innovation while reducing the risk of misuse.
This policy establishes a new, government-wide screening requirements for synthetic DNA and the equipment used to make it. It will ensure companies selling nucleic acid sequences and synthesis equipment know their customers and prevent the malicious use of these materials and tools.
This policy strengthens our Nation’s biosecurity posture by establishing rigorous U.S. government-wide procurement screening and physical security standards for synthetic biology. It replaces outdated “self-attestation” systems with robust, independent verification. It creates a dynamic, SI-powered screening layer that assesses the biological risk from nucleic acid sequences, allowing the U.S. to anticipate and prevent malicious use and help stop dangerous gain-of-function research.
@NIST will issue rigorous new screening standards and @HHSGov and @USDA will certify synthetic biology providers. Together, these measures will strengthen American biosecurity, safeguard responsible innovation, and establish a global standard for safe and transparent synthetic biology tools and research.
Great collaboration with Tongqing Zhou, Danny Douek, Leo Srebryannyy at the NIHVRC @SanghyunLeeLab and led by cofirst authors Zhe Zhao, Paul Tran, Ning Li, Li Ou, and Jaewon Song along with many other key collaborators.
Together this gives important insight into the molecular basis for parahenipavirus entry, pathogenesis, and host range. This will also enable development of therapeutic antibodies and vaccines.
We then synthesized EPCRs from diverse animals to gain insight into EPCR host range. Langya could use EPCR from shrews, humans, and select other mammals. This was governed by variation at the Langya-EPCR interface.
Langya binds to EPCR using a similar mechanism (insertion of a Phe) as EPCR's physiologic ligand Protein C and the malarial parasite protein PfEMP1 highlighting an interesting and unexpected example of convergent evolution
EPCR also mediates entry of closely related Wenzhou and to a lesser extent Mojiang parahenipaviruses. Mojiang was linked to the deaths of three miners in ~2012.